Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
HRSA approves 10 drug companies for participation in the 340B Rebate Model Pilot Program
American Hospital Association
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the 340B Rebate Model Pilot Program.
CMS finalizes GLOBE drug pricing model
American Hospital Association
The Centers for Medicare & Medicaid Services Sept. 30 finalized its Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model.
AHA releases new issue brief on de-escalation strategies
American Hospital Association
The AHA Oct. 1 published an issue brief on how evidence-based de-escalation strategies can help hospitals and health systems prevent violence, improve safety and strengthen trust among patients, families and the workforce.
HHS launches new clinical trials program for drug development
American Hospital Association
The Department of Health and Human Services announced a new clinical trials program through the Advanced Research Projects Agency for Health, or ARPA-H, that is designed to evaluate drugs and biologics faster, at lower cost and with fewer...
Postoperative Pain Management Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
GlobeNewswire, Inc.
New York, USA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Postoperative Pain Management Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The postoperative pain management clinical trial...
MDaudit Ranked the 232nd Fastest-Growing Private Healthcare & Medical Company on the Inc. 5000
GlobeNewswire, Inc.
WELLESLEY, Mass., Aug. 11, 2026 (GLOBE NEWSWIRE) -- MDaudit, an award-winning continuous risk-monitoring platform, today announced that it earned the No. 232 ranking among healthcare and medical companies and No. 2134 overall on the 2026 Inc. 5000...
Beyond the Tobacco and Vapes Act: realising the smoke-free dividend
Royal College of Physicians
In a new article for Clinical Medicine (ClinMed), RCP special adviser on tobacco, Professor Sanjay Agrawal, explores why the next phase of tobacco control must focus not only on reducing overall smoking prevalence.
RCP survey reveals growing patient safety risks as care struggles to keep pace with rising numbers of patients with multiple long-term conditions
Royal College of Physicians
New data from the Royal College of Physicians (RCP) reveals growing concern among physicians that NHS services are not keeping pace with the rising number of patients living with multiple long-term conditions, with two-thirds reporting they have...
Chronic Urticaria Clinical Trial Landscape Becomes Increasingly Crowded with 20+ Pharma Companies | DelveInsight
GlobeNewswire, Inc.
New York, USA, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Chronic Urticaria Clinical Trial Landscape Becomes Increasingly Crowded with 20+ Pharma Companies | DelveInsight The chronic urticaria clinical trial analysis report delivers important insights into...
Beyond the Tobacco and Vapes Act: realising the smoke-free dividend
Royal College of Physicians
In a new article for Clinical Medicine (ClinMed), RCP special adviser on tobacco, Professor Sanjay Agrawal, explores why the next phase of tobacco control must focus not only on reducing overall smoking prevalence.
RCP survey reveals growing patient safety risks as care struggles to keep pace with rising numbers of patients with multiple long-term conditions
Royal College of Physicians
New data from the Royal College of Physicians (RCP) reveals growing concern among physicians that NHS services are not keeping pace with the rising number of patients living with multiple long-term conditions, with two-thirds reporting they have...
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
GlobeNewswire, Inc.
TEL AVIV, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced...
Questex’s Fierce Pharma Unveils Fierce Pharma Week’s 2026 Conference Program, Explores What’s Next in the Pharmaceutical Industry
GlobeNewswire, Inc.
Health Advocate Tamsen Fadal will Deliver Keynote Offering Fresh Perspectives on Leadership, Resilience, Innovation and the Power of Storytelling Fierce Pharma Week Takes Place September 14-17 in Philadelphia; Register Here NEW YORK, July 28, 2026...
Health Department Releases Flu, COVID and RSV Vaccine Recommendations for 2026-27
Vermont Department of Health and Human Services
For Immediate Release: September 30, 2026 Media Contact: Kyle Casteel – Media Lead Communication Office │ Department of Health 802-863-7280 │ [email protected] Health Department Releases Flu, COVID and RSV Vaccine Recommendations for 2026-27...
pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits
GlobeNewswire, Inc.
SAN FRANCISCO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- pMD®, a leading healthcare technology company, today announced it has successfully completed its annual SOC 2® Type II and HIPAA security audits, reaffirming its ongoing investment in protecting...
Joint Commission awards Pollack inaugural Lifetime Service Award
American Hospital Association
Joint Commission announced Sept. 30 that Joint Commission announced today that AHA President and CEO Emeritus Rick Pollack received its inaugural Lifetime Service Award, which honors individuals whose careers have advanced healthcare quality,...
AHA comments on cybersecurity, AI attacks for Senate Homeland Security subcommittee hearing
American Hospital Association
The AHA provided comments Sept. 30 to the Senate Homeland Security and Governmental Affairs Subcommittee on Disaster Management, District of Columbia and Census for a hearing, “Rogue AI: Securing the Homeland Against AI Agent Attacks.” The AHA...
HHS clarifies when state Medicaid agencies can use patient SUD records to verify exemption from community engagement requirements
American Hospital Association
The Department of Health and Human Services Office for Civil Rights released new guidance on statutory and regulatory requirements under 42 CFR Part 2, which protect the confidentiality of substance use disorder patient records.
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
GlobeNewswire, Inc.
Continued improvement: An increased response was seen in participants on litifilimab from week 24 through week 52, with more individuals achieving clear or almost clear skin (27.2%; CLA IGA 0-1) and improvements in disease activity (28.8%;...
White House announces AI-powered website for delivering government information, services
American Hospital Association
Two executive orders on artificial intelligence were released Sept. 29 by the White House.
Sign up for:
Medical Industry Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.